Ledger.Open graph →
SEC Form D · filed October 20, 2020

Nuvation Bio Inc

Offering
$275.3M
Sold
$275.3M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEW YORK, NY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Kim Blickenstaff · New York, NYDirectorClaudio Nessi · Waltham, MADirectorW. A. Vernon · New York, NYDirectorDavid Hung, M.D · Waltham, MAExec · DirectorMichelle Doig · New York, NYDirectorKathryn E. Falberg · Broomfield, CODirectorClaudio Nessi · Waltham, MADirectorDaniel A. Welch · New York, NYDirectorRobert Bazemore · Fremont, CADirectorDavid Hung, M.D · New York, NYExec · DirectorKim Blickenstaff · Lexington, MADirectorMichelle Doig · New York, NYDirectorKathryn E. Falberg · Brisbane, CADirectorClaudio Nessi · Boston, MADirectorW. A. Vernon · New York, NYDirectorDaniel A. Welch · New York, NYDirectorRobert Bazemore · Fremont, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗